# GO	NS	enrichment	name	ratio_in_study	ratio_in_pop	p_uncorrected	depth	study_count	p_fdr_bh	study_items
GO:0003723	MF	e	RNA binding	18/18	1124/6920	5.5216436154220016e-15	3	18	1.4284492033096719e-11	CUS1, CUS2, HSH155, HSH49, IST3, LEA1, MSL1, PRP11, PRP21, PRP9, RSE1, SMB1, SMD1, SMD2, SMD3, SME1, SMX2, SMX3
GO:0003676	MF	e	nucleic acid binding	18/18	1751/6920	1.6934644792583844e-11	2	18	2.1904963039207204e-08	CUS1, CUS2, HSH155, HSH49, IST3, LEA1, MSL1, PRP11, PRP21, PRP9, RSE1, SMB1, SMD1, SMD2, SMD3, SME1, SMX2, SMX3
GO:0030620	MF	e	U2 snRNA binding	4/18	10/6920	6.666231021601934e-09	5	4	5.748513217628068e-06	CUS2, LEA1, MSL1, RSE1
GO:0017069	MF	e	snRNA binding	4/18	25/6920	3.9190981991783744e-07	4	4	0.00025346767603186135	CUS2, LEA1, MSL1, RSE1
GO:1990935	MF	e	splicing factor binding	2/18	2/6920	6.391046853474599e-06	3	2	0.0033067276419877574	SME1, SMX3
GO:0005488	MF	e	binding	18/18	3679/6920	1.2437902879713764e-05	1	18	0.005362809124969918	CUS1, CUS2, HSH155, HSH49, IST3, LEA1, MSL1, PRP11, PRP21, PRP9, RSE1, SMB1, SMD1, SMD2, SMD3, SME1, SMX2, SMX3
